Literature DB >> 1239396

Radioimmunological determination of human C-peptide in serum.

L G Heding.   

Abstract

A routing radioimmunoassay for human C-peptide in serum is described. Antibodies against human C-peptide were raised by immunizing guinea pigs with human b-component. Nine out of 12 animals produced useful antibodies within 6 months. Insulin antibodies coupled to Sepharose were used to bind human proinsulin and insulin in the serum and after centrifugation C-peptide was determined in the supernatant. The detection limit of the assay (calculated as 2 SD from zero) was about 0.003 pmole of C-peptide (in 100 mul). The main sources of error were: (1) Normal and diabetic sera devoid of C-peptide gave a displacement of 125I-Tyr-C-peptide varying from 0 to 0.16 nM (6 different antisera). Only one antiserum (M 1181) showed no displacement, and the values of C-peptide determined with this antiserum in normal and diabetic sera were lower than the values determined with another antiserum, which gave a value of 0.07 nM in the sera free of C-peptide. It is suggested that displacement found with most antisera is due to substances in serum that are not related to C-peptide or proinsulin. (2) Serial dilutions of pancreatic extracts and sera may yield dilution curves slightly different to those of the synthetic standard. Possible explanations are discussed. These sources of error can be eliminated or reduced by the proper selection of antisera. Fasting sera from 15 normals, 8 maturity-onset diabetics and 10 insulin-requiring diabetics showed the following concentrations of C-peptide: (M 1181) 0.35 +/- 0.09, 0.74 +/- 0.51 and 0.21 +/- 0.14 (nM, mean +/- SD). One hour after 1.75 g/kg oral glucose the values increased to 2.24 +/- 0.71, 2.34 +/- 0.24 nM.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1239396     DOI: 10.1007/bf01222104

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  14 in total

1.  Studies on polypeptides. V. Improved synthesis of human proinsulin C-peptide and its benzyloxycarbonyl derivative. Circular dichroism and immunological studies of human C-peptide.

Authors:  V K Naithani; M Dechesne; J Markussen; L G Heding
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1975-06

2.  Plasma proinsulin-like material in insulin treated diabetics.

Authors:  G Fink; J C Cresto; R A Gutman; R L Lavine; A H Rubenstein; L Recant
Journal:  Horm Metab Res       Date:  1974-11       Impact factor: 2.936

3.  Diagnosis of insulinomas by suppression tests.

Authors:  R C Turner; E Harris
Journal:  Lancet       Date:  1974-07-27       Impact factor: 79.321

4.  Preparation of human C-peptide.

Authors:  J Markussen; F Sundby; D G Smyth; A Ko
Journal:  Horm Metab Res       Date:  1971-07       Impact factor: 2.936

5.  Radioimmunological determination of pancreatic and gut glucagon in plasma.

Authors:  L G Heding
Journal:  Diabetologia       Date:  1971-02       Impact factor: 10.122

6.  Synthesis of human connecting peptide derivatives and their immunological properties.

Authors:  N Yanaihara; T Hashimoto; C Yanaihara; M Sakagami
Journal:  Biochem Biophys Res Commun       Date:  1974-08-05       Impact factor: 3.575

7.  [Proinsulin and related substances].

Authors:  J Schlichtkrull
Journal:  Pathol Biol (Paris)       Date:  1971-10

8.  Proinsulin and C-peptide in blood.

Authors:  A H Rubenstein; M B Block; J Starr; F Melani; D F Steiner
Journal:  Diabetes       Date:  1972       Impact factor: 9.461

9.  Studies on polypeptides, VI. Synthesis, circular dichroism and immunological studies of tyrosyl C-peptide of human proinsulin.

Authors:  V K Naithani; M Dechesne; J Markussen; L G Heding; U D Larsen
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1975-08

10.  Elevated circulating proinsulin levels in insulin-requiring diabetic patients.

Authors:  M B Block; M Mako; D F Steiner; A H Rubenstein
Journal:  J Lab Clin Med       Date:  1971-11
View more
  235 in total

1.  Photopheresis at onset of type 1 diabetes: a randomised, double blind, placebo controlled trial.

Authors:  J Ludvigsson; U Samuelsson; J Ernerudh; C Johansson; L Stenhammar; G Berlin
Journal:  Arch Dis Child       Date:  2001-08       Impact factor: 3.791

2.  Multiple disturbances of free fatty acid metabolism in noninsulin-dependent diabetes. Effect of oral hypoglycemic therapy.

Authors:  M R Taskinen; C Bogardus; A Kennedy; B V Howard
Journal:  J Clin Invest       Date:  1985-08       Impact factor: 14.808

3.  Determination of insulin specific IgE in serum of diabetic patients by solid-phase radioimmunoassay.

Authors:  K Falholt
Journal:  Diabetologia       Date:  1982-04       Impact factor: 10.122

4.  Influence of sulfonylureas on the secretion, disposal and effect of insulin.

Authors:  L O Almér; E Johansson; A Melander; E Wåhlin-Boll
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

5.  The difficult choice of treatment for poorly controlled maturity onset diabetes: tablets or insulin?

Authors:  I Peacock; R B Tattersall
Journal:  Br Med J (Clin Res Ed)       Date:  1984-06-30

6.  Improvement of metabolic control in diabetic patients during mebendazole administration: preliminary studies.

Authors:  S Caprio; T K Ray; G Boden; G A Reichard; C R Shuman; R H Smith; M A Mozzoli; V K Dayal; R D Hoeldtke; O E Owen
Journal:  Diabetologia       Date:  1984-07       Impact factor: 10.122

7.  Low subcutaneous degradation and slow absorption of insulin in insulin-dependent diabetic patients during continuous subcutaneous insulin infusion at basal rate.

Authors:  D J Chisholm; E W Kraegen; M J Hewett; S Furler
Journal:  Diabetologia       Date:  1984-08       Impact factor: 10.122

8.  Pancreatic glucagon secretion and exocrine function (BT-PABA test) in chronic pancreatitis.

Authors:  U Keller; E Szöllösy; L Varga; K Gyr
Journal:  Dig Dis Sci       Date:  1984-09       Impact factor: 3.199

9.  Relationships between insulin secretion, insulin action, and fasting plasma glucose concentration in nondiabetic and noninsulin-dependent diabetic subjects.

Authors:  C Bogardus; S Lillioja; B V Howard; G Reaven; D Mott
Journal:  J Clin Invest       Date:  1984-10       Impact factor: 14.808

10.  A comparison of the artificial pancreas (glucose controlled insulin infusion system) and a manual technique for assessing insulin sensitivity during euglycaemic clamping.

Authors:  M Ponchner; R J Heine; A Pernet; I Hanning; A J Francis; D Cook; H Orskov; K G Alberti
Journal:  Diabetologia       Date:  1984-06       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.